ankaflavin and Laryngeal-Neoplasms

ankaflavin has been researched along with Laryngeal-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for ankaflavin and Laryngeal-Neoplasms

ArticleYear
Anti-tumor and anti-inflammatory properties of ankaflavin and monaphilone A from monascus purpureus NTU 568.
    Journal of agricultural and food chemistry, 2011, Feb-23, Volume: 59, Issue:4

    An azaphilonidal derivative monaphilone A (MA) was recently isolated from the fermented products of Monascus purpureus NTU 568 by our laboratory. We report here the exploration of apoptosis-related and anti-inflammatory properties of MA and ankaflavin (AK) by some experiments about inducing death of human laryngeal carcinoma cell line HEp-2 and reducing inflammatory responses on murine macrophage RAW 264.7 cells. We employed a ssDNA enzyme-linked immunosorbent assay (ELISA) kit to investigate the nuclear changes of early apoptosis induced by AK and MA on HEp-2 cells and used a western blot and an enzyme activity assay to demonstrate the activation of caspase-3, caspase-8, and caspase-9 by MA and AK. Our studies revealed that AK and MA may decrease lipopolysaccharide (LPS)-induced inflammatory responses, including nitrite productions and expressions of inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX-2) in RAW 264.7 cells. All evidence support that azaphilonidal derivatives from M. purpureus NTU 568, such as AK and MA, are suitable for the development of chemotherapy or chemopreventive agents.

    Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Apoptosis; Benzopyrans; Caspases; Cell Line; Cell Line, Tumor; Cyclooxygenase 2; Flavins; Humans; Laryngeal Neoplasms; Macrophages; Mice; Monascus; Nitric Oxide Synthase Type II

2011